Chlorpromazine Hydrochloride Injection
» Chlorpromazine Hydrochloride Injection is a sterile solution of Chlorpromazine Hydrochloride in Water for Injection. It contains, in each mL, not less than 23.75 mg and not more than 26.25 mg of C17H19ClN2S·HCl.
Packaging and storage Preserve in single-dose or in multiple-dose containers, preferably of Type I glass, protected from light.
USP Reference standards 11
USP Chlorpromazine Hydrochloride RS.
USP Endotoxin RS.
noteThroughout the following procedures, protect test or assay specimens, the Reference Standard, and solutions containing them, by conducting the procedures without delay, under subdued light, or using low-actinic glassware.
A: Transfer a volume of Injection, equivalent to about 25 mg of chlorpromazine hydrochloride, to a 10-mL volumetric flask, dilute with methanol to volume, and mix (test solution). Dissolve a suitable quantity of USP Chlorpromazine Hydrochloride RS in dilute methanol (9 in 10) to obtain a Standard solution having a known concentration of 2.5 mg per mL. Apply separately 5-µL portions of each of the two solutions to the starting line of a thin-layer chromatographic plate (see Chromatography 621) coated with chromatographic silica gel mixture. Develop the chromatogram in a solvent system consisting of a freshly prepared mixture of equal volumes of ether and ethyl acetate saturated with ammonium hydroxide until the solvent front has moved about 10 cm from the origin. Remove the plate from the developing chamber, air-dry for 20 minutes, then view under short-wavelength UV light: the RF value of the principal spot obtained from the test solution corresponds to that obtained from the Standard solution.
B: It responds to the tests for Chloride 191.
Bacterial endotoxins 85 It contains not more than 6.9 USP Endotoxin Units per mg of chlorpromazine hydrochloride.
pH 791: between 3.4 and 5.4.
Limit of chlorpromazine sulfoxide [noteConduct this test without exposure to daylight, and with the minimum necessary exposure to artificial light.]
Test preparation Pipet 4 mL of the test solution prepared with methanol as directed in Identification test A into a 10-mL volumetric flask, dilute with methanol to volume, and mix.
Standard preparation Dissolve a suitable quantity of USP Chlorpromazine Hydrochloride RS in methanol to obtain a solution having a concentration of 50 µg per mL.
Procedure Apply separate 10-µL portions of the Standard preparation and the Test preparation to the starting line of a thin-layer chromatographic plate coated with a 0.25-mm layer of chromatographic silica gel mixture. Dry the applied solutions with the aid of a stream of nitrogen. Develop the chromatogram, using as the solvent system a freshly prepared mixture of equal volumes of ether and ethyl acetate saturated with ammonium hydroxide, until the solvent front has moved about 13 cm from the origin. Remove the plate from the chamber, and air-dry for 30 minutes. Examine under short-wavelength UV light: the area and intensity of the only other spot in the test specimen chromatogram, other than the principal spot, are not greater than those of the spot from the Standard preparation (5.0%).
Other requirements It meets the requirements under Injections 1.
Assay Transfer an accurately measured volume of Injection, equivalent to about 100 mg of chlorpromazine hydrochloride, to a 500-mL volumetric flask, add 0.1 N hydrochloric acid to volume, and mix. Pipet 10 mL of the solution into a 250-mL separator, add about 20 mL of water, render alkaline with ammonium hydroxide, and extract with four 25-mL portions of ether. Extract the combined ether extracts with four 25-mL portions of 0.1 N hydrochloric acid, collecting the aqueous extracts in a 250-mL volumetric flask. Aerate to remove residual ether, add 0.1 N hydrochloric acid to volume, and mix. Dissolve a suitable quantity, accurately weighed, of USP Chlorpromazine Hydrochloride RS in 0.1 N hydrochloric acid, and dilute quantitatively and stepwise with the same acid to obtain a Standard solution having a known concentration of about 8 µg per mL. Concomitantly determine the absorbances of both solutions in 1-cm cells at the wavelength of maximum absorbance at about 254 nm and at 277 nm, with a suitable spectrophotometer, using 0.1 N hydrochloric acid as the blank. Calculate the quantity, in mg, of C17H19ClN2S·HCl in each mL of the Injection taken by the formula:
12.5C(A254 A277)U / V(A254 A277)Sin which C is the concentration, in µg per mL, of USP Chlorpromazine Hydrochloride RS in the Standard solution, V is the volume, in mL, of Injection taken, and the parenthetic expressions are the differences in the absorbances of the two solutions at the wavelengths indicated by the subscripts, for the solution from the Injection (U) and the Standard solution (S), respectively.
Auxiliary Information Please check for your question in the FAQs before contacting USP.
USP32NF27 Page 1915